If the expression of Ki-67 and GPC-3 could be evaluated before surgery, the indirect method to determine the proliferation of HCC cells would be of positive significance for guiding the rational formulation of clinical treatment plans and predicting the prognosis of patients. This evidence concerns the gene GPC3 and hepatocellular carcinoma.